Peptide Lexicon

Tirzepatide

Tirzepatide in the T&T Supplies peptide lexicon: research reference with mechanism, reported effects, limitations and literature data. Evidence grade A.

Mechanism

Dual GIP/GLP-1 receptor agonist. More potent than semaglutide. Increases insulin secretion. Slows gastric emptying. Increases satiety. Improves glucose control.

Reported effects

Superior weight loss vs GLP-1 monotherapy. Improved metabolic control. Lean mass retention (better than semaglutide). Cardiovascular benefits in obese.

Limitations

GLP-1 class side effects: nausea, vomiting, diarrhea during titration. Ozempic shortage issues persist. Off-label use for cosmetic/performance.

Literature data

Dosage (literature)

0.5-2.4mg weekly subcut. Titrate over 12-16 weeks

Timing

Weekly injection any time

Cycling

Continuous once titrated. Maintenance phase.

Tirzepatide in the shop

Information for research purposes only.